Publication: Prevalence of severe esophagitis in Spain. Results of the PRESS study (Prevalence and Risk factors for Esophagitis in Spain: A cross-sectional study).
No Thumbnail Available
Identifiers
Date
2015-07-24
Authors
Piqué, Núria
Ponce, Marta
Garrigues, Vicente
Rodrigo, Luis
Calvo, Félix
de Argila, Carlos Martín
Borda, Fernando
Naranjo, Antonio
Alcedo, Javier
José Soria, María
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
*N.P. and M.P. contributed equally to this study.The current prevalence of esophagitis in southern Europe is unknown. In addition, the risk factors for reflux esophagitis are not fully understood. The objective of this article is to assess the prevalence and risk factors for esophagitis in Spain. A prospective, observational, cross-sectional, multicenter study (PRESS study) was conducted among 31 gastrointestinal endoscopy units throughout Spain. A total of 1361 patients undergoing upper gastrointestinal endoscopy were enrolled. Sociodemographic, clinical and treatment data were recorded. A total of 95% of patients were Caucasian and 52% were male (mean age: 53 ± 17 years). The most frequent symptoms prompting endoscopy were heartburn (40%), regurgitation (26%) and dysphagia (15%). Fifty-four percent of patients undergoing endoscopy were receiving proton pump inhibitor (PPI) treatment. Esophagitis (mainly mild-moderate) was present in 154 (12.4%) patients. The severe form was recorded in only 11 (0.8%) patients. Multivariate analysis results indicated that the likelihood of esophagitis was higher in men (OR = 1.91, 95% CI = 1.31-2.78), in patients with high GERD-Q scores (OR = 1.256, 95% CI = 1.176-1.343), weight increase (OR = 1.014, 95% CI = 1.003-1.025) and high alcohol consumption (OR = 2.49, 95% CI = 1.16-5.36). Severe esophagitis is a rare finding in the Spanish population. Male gender, high GERD-Q score, weight increase and high alcohol consumption are main risk factors for its appearance.
Description
MeSH Terms
DeCS Terms
CIE Terms
Keywords
Barrett’s esophagus, Endoscopy, gastro-esophageal reflux disease (GERD), gastrointestinal symptoms, hiatal hernia, nonsteroidal anti-inflammatory drugs (NSAID), questionnaires, severe esophagitis